Opna Bio
PrivateLast Round
Series A
Nov 21, 2022
Total Funding Raised
$38M
Company Overview
Opna Bio is a clinical-stage biopharmaceutical company that discovers and develops novel oncology therapeutics targeting immune suppression and other hallmarks of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Opna Bio Comparables
Compare Opna Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellCentric | 84% | |
| C4 Therapeutics | 76% | |
| Novartis | 75% |
Opna Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 21, 2022 |
Opna Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A |
| Northpond Ventures | Series A |
| Menlo Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 22, 2025
Added ByPost, a logistics/shipping SMB, as a customer.
- Nov 22, 2025
Added Twinhub (Pvt) Ltd. from IT Services and IT Consulting.
Opna Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Opna Bio's valuation, stock price, and market status.
Is Opna Bio a public or private company?
Opna Bio is a private company.
What is the current stock price of Opna Bio?
Opna Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Opna Bio worth (valuation)?
Valuation information for Opna Bio is not publicly available.
Can I buy Opna Bio stock?
Opna Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Opna Bio's last funding round?
Opna Bio's most recent funding round was Seed on September 5, 2023.
Who are the main investors in Opna Bio?
Key investors in Opna Bio include Longitude Capital, Northpond Ventures, Atomico.
Will Opna Bio IPO soon?
No public IPO plans have been announced for Opna Bio.
How can I track Opna Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Opna Bio's secondary market activity and sign up for updates.